Egyptian International Pharmaceutical Industries Company (EGX:PHAR)
Egypt · Delayed Price · Currency is EGP 131.50
-2.32 (-1.73%)
At close: Aug 25, 2026
EGX:PHAR Financials Overview
Financials in millions EGP. Fiscal year is January - December.
Millions EGP. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 9,884 | 9,441 | 7,591 | 5,232 | 3,955 | 3,409 |
Revenue Growth | 12.08% | 24.38% | 45.09% | 32.27% | 16.03% | 18.13% |
Gross Profit Gross Profit Growth | 4,045 | 4,141 | 3,346 | 2,248 | 1,558 | 1,452 |
Operating Income Operating Income Growth | 2,085 | 2,341 | 1,507 | 1,211 | 662 | 776.85 |
Net Income Net Income Growth | 1,240 | 1,442 | 1,096 | 822.32 | 642.98 | 487.75 |
Earnings Per Share EPS Growth | 7.65 | 8.90 | 7.37 | 5.53 | 6.48 | 4.92 |
EPS Growth | 6.03% | 20.80% | 33.25% | -14.74% | 31.83% | -1.36% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Egypt Egypt Growth | 6,816 | 6,425 | 5,055 | 3,625 | 2,983 | 2,649 |
Export Export Growth | 3,006 | 2,967 | 2,500 | 1,592 | 965.1 | 752.98 |
Unallocated Unallocated Growth | 62.26 | 49.37 | 35.84 | 15.08 | 7.39 | 7.11 |
Total Total Growth | 9,884 | 9,441 | 7,591 | 5,232 | 3,956 | 3,409 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 217.97 | 1,433 | 1,295 | 675.8 | 482.97 | 311.59 |
Total Debt Total Debt Growth | 10,059 | 8,812 | 9,229 | 4,918 | 2,862 | 1,763 |
Net Cash (Debt) Net Cash Growth | -9,841 | -7,379 | -7,933 | -4,242 | -2,379 | -1,452 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -60.69 | -45.54 | -53.33 | -28.52 | -23.99 | -14.64 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -183.1 | 1,094 | -1,274 | 92.48 | -296.81 | 383.82 |
Capital Expenditures CapEx Growth | -1,289 | -1,355 | -2,846 | -2,290 | -562.95 | -437.09 |
Free Cash Flow Free Cash Flow Growth | -1,472 | -261.15 | -4,121 | -2,198 | -859.77 | -53.27 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 40.93% | 43.86% | 44.08% | 42.98% | 39.40% | 42.59% |
Operating Margin | 21.09% | 24.80% | 19.85% | 23.14% | 16.74% | 22.79% |
Pretax Margin | 15.25% | 18.76% | 19.88% | 20.43% | 20.07% | 18.93% |
Profit Margin | 12.55% | 15.27% | 14.44% | 15.72% | 16.26% | 14.31% |
FCF Margin | -14.90% | -2.77% | -54.29% | -42.01% | -21.74% | -1.56% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 26, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 1.500 | - | 1.500 | 1.000 | 1.000 | 1.500 |
Dividend Per Share Growth | 16.67% | - | 50.00% | 0% | -33.33% | - |
Dividend Yield | 1.16% | - | 3.62% | 3.19% | 4.40% | 6.24% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 26, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 17.19 | 9.07 | 6.23 | 6.60 | 5.63 | 8.52 |
Forward PE | 20.42 | 9.34 | 7.03 | 5.92 | 5.77 | 6.23 |
PS Ratio | 2.25 | 1.39 | 0.90 | 1.04 | 0.92 | 1.22 |